Wall Street Journal [1] |
Intarcia's Diabetes Treatment Clears Key Test [1]
Wall Street Journal The results build on earlier trials to suggest that the once-a-year treatment could be an important option in the sprawling diabetes market. Two studies presented in June at the American Diabetes Association meeting in Boston showed the pump achieved … This startup may have just revolutionized Type 2 diabetes treatment [2]Fortune Hayward-made diabetes treatment [3] beats $6B Merck drug in head-to-head trialSan Francisco Business Times (blog) Intarcia's diabetes–treating implant tops Januvia in a head-to-head test [4]FierceBiotech NH Voice [5] –PR Newswire (press release) [6] –BioPharma Dive [7] all 22 news articles » [8] |
More details can be found at www.diabeteshowto.com [9]